ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Single-Cell Transcriptomic Analysis Reveals the Crosstalk Propensity Between the Tumor Intermediate State and the CD8+T Exhausted State to be Associated with Clinical Benefits in Melanoma

Zhu, Jiali; Yan, Min; Yan, Haoteng; Xu, Liwen; Jiang, Zedong; Liao, Gaoming; Zhou, Yao; Liu, Wei; Liang, Xin; Li, Xia*; Xiao, Yun*; Zhang, Yunpeng*哈尔滨医科大学; y
Frontiers in Immunology2022-7-12DOI: 10.3389/fimmu.2022.766852
2被引4阅读
引用收藏
分享

摘要

Heterogeneous crosstalk between tumor cells and CD8+ T cells leads to substantial variation in clinical benefits from immunotherapy in melanoma. Due to spatial distribution and functional state heterogeneity, it is still unknown whether there is a crosstalk propensity between tumor cells and CD8+ T cells in melanoma, and how this crosstalk propensity affects the clinical outcome of patients. Using public single-cell transcriptome data, extensive heterogeneous functional states and ligand-receptor interactions of tumor cells and CD8+ T cells were revealed in melanoma. Furthermore, based on the association between cell-cell communication intensity and cell state activity in a single cell, we identified a crosstalk propensity between the tumor intermediate state and the CD8+ T exhausted state. This crosstalk propensity was further verified by pseudo-spatial proximity, spatial co-location, and the intra/intercellular signal transduction network. At the sample level, the tumor intermediate state and the CD8+ T exhausted state synergistically indicated better prognosis and both reduced in immunotherapy-resistant samples. The risk groups defined based on these two cell states could comprehensively reflect tumor genomic mutations and anti-tumor immunity information. The low-risk group had a higher BRAF mutation fraction as well as stronger antitumor immune response. Our findings highlighted the crosstalk propensity between the tumor intermediate state and the CD8+ T exhausted state, which may serve as a reference to guide the development of diagnostic biomarkers for risk stratification and therapeutic targets for new therapeutic strategies.

学科与关键词

关键词
cell-cell communicationcell statemelanomasingle-cell transcriptome analysisCD8+T cell
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-07-12
卷期
第 13 卷
页码
766852
DOI
10.3389/fimmu.2022.766852
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Key R&D Program of China [2018YFC2000100]; National Natural Science Foundation of China [62172131, 32070673, 31871336]; Heilongjiang Provincial Natural Science Foundation [YQ2019C012, YQ2021C026]; Heilongjiang Postdoctoral Foundation [LBH-Q18099]; Program for Young Scholars with Creative Talents in Heilongjiang Province [UNPYSCT-2017059]; Heilongjiang Touyan Innovation Team Program

作者

  • Z

    Zhu, Jiali (第一作者)

    harbin med univ

  • Y

    Yan, Min

    harbin med univ

查看全部 12 位作者收起作者
  • Y

    Yan, Haoteng

    harbin med univ

  • X

    Xu, Liwen

    harbin med univ

  • J

    Jiang, Zedong

    harbin med univ

  • L

    Liao, Gaoming

    harbin med univ

  • Z

    Zhou, Yao

    harbin med univ

  • L

    Liu, Wei

    harbin med univ

  • L

    Liang, Xin

    harbin med univ

  • L

    Li, Xia (通讯)

    harbin med univ

  • X

    Xiao, Yun (通讯)

    harbin med univ

  • Z

    Zhang, Yunpeng (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417